Ipamorelin (RUO) Selective GHS R1a Agonist USA Supplier The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn Ipamorelin Peptide Growth Hormone Research Compound